The Journal of Immunology, Vol 155, Issue 5 2670-2678, Copyright © 1995 by American Association of Immunologists

ARTICLES

Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals

C Brander, D Mauri-Hellweg, F Bettens, H Rolli, M Goldman and WJ Pichler
Institute of Immunology and Allergology, Inselspital, Bern, Switzerland.

To investigate the role of T cells in drug allergy, we stimulated PBMC from penicillin-allergic patients with reactive penicillin G itself or penicillin G coupled with human serum albumin (BPO-HSA). T cell clones specific for penicillin G or BPO-HSA were established and their phenotype and reactivity to both forms of the beta-lactam were analyzed. T cell clones stimulated by penicillin G were CD4 and CD8 positive, whereas BPO-HSA stimulated the growth of CD4+ T cells. The penicillin G-specific clones were HLA class I or class II restricted and processing was not required as fixed APC could still present penicillin G. In contrast, BPO-HSA has to undergo processing to stimulate BPO-HSA-specific T cell clones. In addition to classical APC, activated MHC class II expressing T cells could also restimulate the penicillin G-specific clones, indicating that various cell types might serve as APC. Penicillin G and BPO-HSA-specific T cell clones produced a heterogeneous cytokine pattern as most clones produced high amounts of IL-2, IFN-gamma, TFN-alpha, and rather variable levels of IL-4 and IL-5. Since no Ag processing was required, penicillin G may stimulate T cells by binding directly to MHC molecules on the cell surface or to their embedded peptide. Alternatively, it may bind to soluble proteins like HSA, which are processed and subsequently presented in an immunogenic form. These different modes of presentation, which elicit a variety of immunological reactivities, may explain the great heterogeneity of the clinical pictures seen in penicillin allergy.

This article has been cited by other articles:

				D. A. Schmid, J. P. H. Depta, M. Luthi, and W. J. Pichler Transfection of Drug-Specific T-Cell Receptors into Hybridoma Cells: Tools to Monitor Drug Interaction with T-Cell Receptors and Evaluate Cross-Reactivity to Related Compounds Mol. Pharmacol., July 1, 2006; 70(1): 356 - 365. [Abstract] [Full Text] [PDF]

				D. J. Naisbitt, J. Farrell, P. J. Chamberlain, J. E. Hopkins, N. G. Berry, M. Pirmohamed, and B. K. Park Characterization of the T-Cell Response in a Patient with Phenindione Hypersensitivity J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1058 - 1065. [Abstract] [Full Text] [PDF]

				W. J. Pichler Delayed Drug Hypersensitivity Reactions Ann Intern Med, October 21, 2003; 139(8): 683 - 693. [Abstract] [Full Text] [PDF]

				S. von Greyerz, G. Bultemann, K. Schnyder, C. Burkhart, B. Lotti, Y. Hari, and W. J. Pichler Degeneracy and additional alloreactivity of drug-specific human {{alpha}}{beta}+ T cell clones Int. Immunol., July 1, 2001; 13(7): 877 - 885. [Abstract] [Full Text] [PDF]

				F. Brugnolo, F. Annunziato, S. Sampognaro, P. Campi, M. Manfredi, A. Matucci, M. Blanca, S. Romagnani, E. Maggi, and P. Parronchi Highly Th2-Skewed Cytokine Profile of {beta}-Lactam-Specific T Cells from Nonatopic Subjects with Adverse Drug Reactions J. Immunol., July 15, 1999; 163(2): 1053 - 1059. [Abstract] [Full Text] [PDF]

				E. Padovan, S. v. Greyerz, W. J. Pichler, and H. U. Weltzien Antigen-Dependent and -Independent IFN-{gamma} Modulation by Penicillins J. Immunol., January 15, 1999; 162(2): 1171 - 1177. [Abstract] [Full Text] [PDF]

				S. von Greyerz, M. P. Zanni, K. Frutig, B. Schnyder, C. Burkhart, and W. J. Pichler Interaction of Sulfonamide Derivatives with the TCR of Sulfamethoxazole-Specific Human {alpha}{beta}+ T Cell Clones J. Immunol., January 1, 1999; 162(1): 595 - 602. [Abstract] [Full Text] [PDF]

				L. Li, Y. Li, S. W. Reddel, M. Cherrian, D. S. Friend, R. L. Stevens, and S. A. Krilis Identification of Basophilic Cells that Express Mast Cell Granule Proteases in the Peripheral Blood of Asthma, Allergy, and Drug-Reactive Patients J. Immunol., November 1, 1998; 161(9): 5079 - 5086. [Abstract] [Full Text] [PDF]